Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting

Objectives: Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries (PA/VSD/MAPCAs) is complex and diverse that has led to a variety of treatment strategies. Experience has been largely obtained in the advanced countries. The clinical diversity is greater in Chi...

Full description

Bibliographic Details
Main Authors: Ming-Hui Zou, Li Ma, Yan-Qing Cui, Huai-Zhen Wang, Wen-Lei Li, Jia Li, Xin-Xin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.665038/full
id doaj-a40918db177e4147aaad3aee4f5f23b6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ming-Hui Zou
Ming-Hui Zou
Li Ma
Li Ma
Yan-Qing Cui
Yan-Qing Cui
Huai-Zhen Wang
Huai-Zhen Wang
Wen-Lei Li
Wen-Lei Li
Jia Li
Jia Li
Xin-Xin Chen
Xin-Xin Chen
spellingShingle Ming-Hui Zou
Ming-Hui Zou
Li Ma
Li Ma
Yan-Qing Cui
Yan-Qing Cui
Huai-Zhen Wang
Huai-Zhen Wang
Wen-Lei Li
Wen-Lei Li
Jia Li
Jia Li
Xin-Xin Chen
Xin-Xin Chen
Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting
Frontiers in Cardiovascular Medicine
pulmonary atresia
ventricular septal defect
major aortopulmonary collateral arteries
unifocalization
rehabilitation
author_facet Ming-Hui Zou
Ming-Hui Zou
Li Ma
Li Ma
Yan-Qing Cui
Yan-Qing Cui
Huai-Zhen Wang
Huai-Zhen Wang
Wen-Lei Li
Wen-Lei Li
Jia Li
Jia Li
Xin-Xin Chen
Xin-Xin Chen
author_sort Ming-Hui Zou
title Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting
title_short Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting
title_full Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting
title_fullStr Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting
title_full_unstemmed Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing Setting
title_sort outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: a tailored approach in a developing setting
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2021-04-01
description Objectives: Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries (PA/VSD/MAPCAs) is complex and diverse that has led to a variety of treatment strategies. Experience has been largely obtained in the advanced countries. The clinical diversity is greater in China. We evaluated our surgical approaches and outcomes of these patients.Methods: We reviewed 127 patients undergoing varied surgeries in our center in 2010–2019.Results: Thirty patients underwent single-stage complete repair by unifocalizing MAPCAs and VSD closure (aged 3.9–131.4 months, median 22) with 3 (10%) early deaths. Ninety-seven underwent the first-stage rehabilitation strategy including systemic-to-pulmonary shunt in 29 (aged 0.5–144 month, median 8), and palliative RV-PA conduit in 68 (aged 2.2–209.6 months, median 14) with 5 (5.2%) early deaths. Eight-one patients (63.8%) eventually achieved complete repair with a median right/left ventricular (RV/LV) pressure ratio of 0.7 (ranged 0.4–1.0). Fourteen patients (11.0%) accepted palliation as final destination. Survival for the entire cohort was 89.5, 85.2, and 76.1% at 1, 5, and 10 years, respectively. Survival for those undergoing complete repair was 88.2 and 76.6% at 1 and 5 year, respectively. RV/LV pressure ratio ≥0.8 was risk factor for mortality (HR10.3, p = 0.003).Conclusions: Our cohort, the largest from China, had distinctive clinical features with substantially wider age range and higher RV/LV pressure ratio. Using the combined approaches tailored to individual patients, complete repair was achieved in 64% of patients. The early and intermediate outcomes are acceptable compared to many of the previous reports.
topic pulmonary atresia
ventricular septal defect
major aortopulmonary collateral arteries
unifocalization
rehabilitation
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.665038/full
work_keys_str_mv AT minghuizou outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT minghuizou outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT lima outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT lima outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT yanqingcui outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT yanqingcui outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT huaizhenwang outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT huaizhenwang outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT wenleili outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT wenleili outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT jiali outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT jiali outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT xinxinchen outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
AT xinxinchen outcomesafterrepairofpulmonaryatresiawithventricularseptaldefectandmajoraortopulmonarycollateralarteriesatailoredapproachinadevelopingsetting
_version_ 1721527664490053632
spelling doaj-a40918db177e4147aaad3aee4f5f23b62021-04-14T04:19:03ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-04-01810.3389/fcvm.2021.665038665038Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries: A Tailored Approach in a Developing SettingMing-Hui Zou0Ming-Hui Zou1Li Ma2Li Ma3Yan-Qing Cui4Yan-Qing Cui5Huai-Zhen Wang6Huai-Zhen Wang7Wen-Lei Li8Wen-Lei Li9Jia Li10Jia Li11Xin-Xin Chen12Xin-Xin Chen13Department of Cardiovascular Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaDepartment of Cardiovascular Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaDepartment of Cardiovascular Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaDepartment of Cardiovascular Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaDepartment of Cardiovascular Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaClinical Physiology Laboratory, Guangzhou Women and Children’s Medical Center, Institute of Pediatrics, Guangzhou Medical University, Guangdong, ChinaDepartment of Cardiovascular Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaGuangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, ChinaObjectives: Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries (PA/VSD/MAPCAs) is complex and diverse that has led to a variety of treatment strategies. Experience has been largely obtained in the advanced countries. The clinical diversity is greater in China. We evaluated our surgical approaches and outcomes of these patients.Methods: We reviewed 127 patients undergoing varied surgeries in our center in 2010–2019.Results: Thirty patients underwent single-stage complete repair by unifocalizing MAPCAs and VSD closure (aged 3.9–131.4 months, median 22) with 3 (10%) early deaths. Ninety-seven underwent the first-stage rehabilitation strategy including systemic-to-pulmonary shunt in 29 (aged 0.5–144 month, median 8), and palliative RV-PA conduit in 68 (aged 2.2–209.6 months, median 14) with 5 (5.2%) early deaths. Eight-one patients (63.8%) eventually achieved complete repair with a median right/left ventricular (RV/LV) pressure ratio of 0.7 (ranged 0.4–1.0). Fourteen patients (11.0%) accepted palliation as final destination. Survival for the entire cohort was 89.5, 85.2, and 76.1% at 1, 5, and 10 years, respectively. Survival for those undergoing complete repair was 88.2 and 76.6% at 1 and 5 year, respectively. RV/LV pressure ratio ≥0.8 was risk factor for mortality (HR10.3, p = 0.003).Conclusions: Our cohort, the largest from China, had distinctive clinical features with substantially wider age range and higher RV/LV pressure ratio. Using the combined approaches tailored to individual patients, complete repair was achieved in 64% of patients. The early and intermediate outcomes are acceptable compared to many of the previous reports.https://www.frontiersin.org/articles/10.3389/fcvm.2021.665038/fullpulmonary atresiaventricular septal defectmajor aortopulmonary collateral arteriesunifocalizationrehabilitation